Vircell launches the 2nd Generation of SPEED-OLIGO® NOVEL INFLUENZA A H1N1

The new updated product makes it possible to distinguish between seasonal and nH1N1 flu

As part of its innovative R&D program, Vircell launches the recent optimization of its product SPEED-OLIGO® NOVEL INFLUENZA A H1N1 (Ref.SP015).

The 2nd Generation of this product includes an additional test line in the dipstick, which is specific for generic Influenza A. From now on, SPEED-OLIGO® NOVEL INFLUENZA A H1N1 will be able to distinguish between seasonal and nH1N1 flu.

Furthermore, the new 2nd Generation will include an improved amplification control line which apart from checking the correct operation of the PCR Mix and the absence of inhibitors, will be able to confirm the quality of the genetic material in the sample by amplifying human β globulin gene.

Vircell completes its product line for Novel Influenza A diagnosis with the launching of the new quantified PCR control: NOVEL INFLUENZA A H1N1 RNA CONTROL (Ref. MBC082).